首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Cytotoxicity against human peripheral blood mononuclear cells and T cell lines mediated by anti-T cell immunotoxins in the absence of added potentiator.
【2h】

Cytotoxicity against human peripheral blood mononuclear cells and T cell lines mediated by anti-T cell immunotoxins in the absence of added potentiator.

机译:在不添加增效剂的情况下针对由抗T细胞免疫毒素介导的人外周血单核细胞和T细胞系的细胞毒性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Several in vitro assays have indicated that anti-T cell immunotoxins (IT), composed of monoclonal antibodies (MoAbs) conjugated to ricin A chain (RTA), are maximally effective against T cells only in the presence of potentiators. It was thought that such IT might not be sufficiently cytotoxic to deplete T cells in vivo upon administration to patients. Therefore, we have re-evaluated the in vitro assays and report herein that even with a short exposure time (2 h), the two anti-T cell IT, H65-RTA (anti-CD5 MoAb coupled to RTA) and 4MRTA (anti-CD7 MoAb coupled to RTA30), were specifically cytotoxic for peripheral blood mononuclear cells (PBMC) in the absence of potentiators. Moreover, as has been reported for IT when tested against T cell lines, prolonging the exposure time of the IT with PBMC from 2 h to as long as 90 h, without added potentiators, enhanced their cytotoxicity from 2- to 40-fold. In contrast, most T cell lines were more sensitive to IT in the presence of potentiator, and IT cytotoxicity was much less enhanced by prolonging the exposure time. Thus, T cell lines may not serve as accurate models to determine the efficacy of IT against PBMC in vitro or in vivo. We conclude that IT-induced cytotoxicity of PBMC can be demonstrated in vitro at pharmacologically achievable concentrations in the absence of added potentiators.
机译:几种体外试验表明,由与蓖麻毒素A链(RTA)偶联的单克隆抗体(MoAbs)组成的抗T细胞免疫毒素(IT)仅在增效剂存在时才对T细胞有效。据认为,这种IT在给予患者后可能没有足够的细胞毒性以体内耗尽T细胞。因此,我们已经重新评估了体外测定,并在此报告了即使在较短的暴露时间(2小时)下,两种抗T细胞IT,H65-RTA(与RTA偶联的抗CD5 MoAb)和4MRTA(抗-CD7 MoAb与RTA30偶联)在缺乏增强剂的情况下对外周血单个核细胞(PBMC)具有特异性细胞毒性。此外,正如针对T细胞系测试IT的报道,不添加增效剂的情况下,PBMC将IT的暴露时间从2小时延长至90小时,而没有添加增效剂,则将其细胞毒性从2倍提高到40倍。相比之下,大多数T细胞系在增效剂存在下对IT更为敏感,而延长暴露时间则对IT细胞毒性的增强作用较小。因此,在体外或体内,T细胞系可能无法用作确定IT对抗PBMC疗效的准确模型。我们得出的结论是,在不添加增效剂的情况下,可以在药理学上可实现的浓度下证明IT诱导的PBMC的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号